Evidence map›Paper›PMID 21694532›Full record

GuidelineJournal of pediatric gastroenterology and nutrition2011

Skeletal health of children and adolescents with inflammatory bowel disease.

Helen Pappa, Meena Thayu, Francisco Sylvester, Mary Leonard, Babette Zemel, Catherine Gordon

Erratum issued 2 registry-linked trialsOpen access · greenAbstract readPractice Guideline
In one paragraph

Guideline in Journal of pediatric gastroenterology and nutrition, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02076750 phase1 / phase2completednot on this mapstarted 2013, after this paper: background citation

Weekly Vitamin D3 for Treatment of Hypovitaminosis D in Children and Adolescents With Inflammatory Bowel Disease

TypeinterventionalSponsorEmory UniversityRan2013 to 2014Enrolled34ConditionsInflammatory Bowel Diseases, Skin PigmentationArmsVitamin D3 (cholecalciferol)
NCT05309590 active not recruitingnot on this mapstarted 2014, after this paper: background citation

Prospective Pilot Study Evaluating the Efficacy of Low-Dose Topical Steroids in Maintaining Histologic Remission of Eosinophilic Esophagitis in Children

Typeobservational_patient_registrySponsorAnn & Robert H Lurie Children's Hospital of ChicagoRan2014 to 2027Enrolled50ConditionsEosinophilic EsophagitisArmsDose
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 127 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Medication-Related Impacts on Pediatric Bone Health.Journal of the Pediatric Orthopaedic Society of North America · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. [Analysis of nutritional status before and after different induction therapies in children with Crohn's disease].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025
    Article
  16. Bone Health in Paediatric Inflammatory Bowel Disease.Diagnostics (Basel, Switzerland) · 2025
    Review
  17. Review
  18. Inflammatory Bowel Disease in Children.Indian journal of pediatrics · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Helen PappaDivision of Gastroenterology and Nutrition, Children's Hospital Boston, Boston, MA 02115, USA. helen.pappa@childrens.harvard.edu
Meena Thayu
Francisco Sylvester
Mary Leonard
Babette Zemel
Catherine Gordon
Children's Hospital of Philadelphia · USBoston Children's Hospital · USConnecticut Children's Medical Center · USHarvard University Press · US

Funding

Optimization of vitamin D status and its effects on bone health of youth with IBDK23DK076979 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI PAPPA, HELEN M · 2008 to 2012
$902k
NIDDK NIH HHS K23 DK076979
6 · The paper itself

Abstract

Current evidence points to suboptimal bone health in children and adolescents with inflammatory bowel disease (IBD) when compared with their healthy peers. This compromise is evident from diagnosis. The clinical consequences and long-term outcome of this finding are still unknown. The mechanism of suboptimal bone health in children and adolescents with IBD lays mainly in reduced bone formation, but also reduced bone resorption, processes necessary for bone growth. Factors contributing to this derangement are inflammation, delayed growth and puberty, lean mass deficits, and use of glucocorticoids. We recognize that evidence is sparse on the topic of bone health in children and adolescents with IBD. In this clinical guideline, based on current evidence, we provide recommendations on screening and monitoring bone health in children and adolescents with IBD, including modalities to achieve this and their limitations; monitoring of parameters of growth, pubertal development, and reasons for concern; evaluation of vitamin D status and vitamin D and calcium intake; exercise; and nutritional support. We also report on the current evidence of the effect of biologics on bone health in children and adolescents with IBD, as well as the role of bone active medications such as bisphosphonates. Finally, we summarize the existing numerous gaps in knowledge and potential subjects for future research endeavors.

Indexed as

AdolescentAdultAge FactorsAnimalsBone DiseasesChildChild DevelopmentEvidence-Based MedicineHumansInflammatory Bowel DiseasesNutritional StatusRisk Factors

Identifiers

PMID21694532
PMCPMC3122140
OpenAlexW2112095609

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.